Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Allopurinol Compared With Allopurinol Administered Alone in Adult Subjects With Gout
Brief Summary: This is a Phase 2a, randomized, open-label, multicenter study to assess the pharmacodynamic (PD) effects of RDEA3170 administered in combination with allopurinol compared with allopurinol administered alone in adult subjects with gout.


Options:
A: Arm Label: Febuxostat; Type: EXPERIMENTAL; Interventions: Drug: Febuxostat | Arm Label: Allopurinol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Allopurinol | Intervention Type: DRUG; Name: Febuxostat; Assigned to Arm(s): Febuxostat | Intervention Type: DRUG; Name: Allopurinol; Assigned to Arm(s): Allopurinol
B: Arm Label: RDEA3170 2.5 mg, 7.5 mg and 15 mg; Type: EXPERIMENTAL; Interventions: Drug: RDEA3170 2.5 mg, Drug: allopurinol 300 mg | Arm Label: RDEA3170 5 mg, 10 mg and 20 mg; Type: EXPERIMENTAL; Interventions: Drug: RDEA3170 2.5 mg, Drug: allopurinol 300 mg | Intervention Type: DRUG; Name: RDEA3170 2.5 mg; Assigned to Arm(s): RDEA3170 2.5 mg, 7.5 mg and 15 mg, RDEA3170 5 mg, 10 mg and 20 mg | Intervention Type: DRUG; Name: allopurinol 300 mg; Assigned to Arm(s): RDEA3170 2.5 mg, 7.5 mg and 15 mg, RDEA3170 5 mg, 10 mg and 20 mg
C: Arm Label: lesinurad 200 mg + allopurinol; Type: EXPERIMENTAL; Interventions: Drug: Lesinurad, Drug: Allopurinol | Arm Label: lesinurad 400 mg + allopurinol; Type: EXPERIMENTAL; Interventions: Drug: Lesinurad, Drug: Allopurinol | Arm Label: Placebo + allopurinol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Allopurinol | Intervention Type: DRUG; Name: Lesinurad; Assigned to Arm(s): lesinurad 200 mg + allopurinol | Intervention Type: DRUG; Name: Lesinurad; Assigned to Arm(s): lesinurad 400 mg + allopurinol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo + allopurinol | Intervention Type: DRUG; Name: Allopurinol; Assigned to Arm(s): Placebo + allopurinol, lesinurad 200 mg + allopurinol, lesinurad 400 mg + allopurinol
D: Arm Label: Allopurinol / Sham Comparator (Febuxostat); Type: ACTIVE_COMPARATOR; Interventions: Drug: allopurinol capsule, 100-800 mg by mouth once daily, Drug: Placebo, vehicle control (febuxostat-shaped) | Arm Label: Febuxostat / Sham Comparator (Allopurinol); Type: ACTIVE_COMPARATOR; Interventions: Drug: febuxostat tablet 40-120 mg by mouth once daily, Drug: Placebo, vehicle control (allopurinol-shaped) | Intervention Type: DRUG; Name: allopurinol capsule, 100-800 mg by mouth once daily; Assigned to Arm(s): Allopurinol / Sham Comparator (Febuxostat) | Intervention Type: DRUG; Name: febuxostat tablet 40-120 mg by mouth once daily; Assigned to Arm(s): Febuxostat / Sham Comparator (Allopurinol) | Intervention Type: DRUG; Name: Placebo, vehicle control (febuxostat-shaped); Assigned to Arm(s): Allopurinol / Sham Comparator (Febuxostat) | Intervention Type: DRUG; Name: Placebo, vehicle control (allopurinol-shaped); Assigned to Arm(s): Febuxostat / Sham Comparator (Allopurinol)

Answer: B